Viewing Study NCT00728195


Ignite Creation Date: 2025-12-24 @ 1:41 PM
Ignite Modification Date: 2026-01-18 @ 4:39 AM
Study NCT ID: NCT00728195
Status: COMPLETED
Last Update Posted: 2014-03-26
First Post: 2008-07-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Efficacy and Safety Study of 3 Fixed Doses of JNJ-37822681 in Participants With Schizophrenia
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Schizophrenia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Schizophrenia View
None Central Nervous System View
None JNJ-37822681 View